James Helliwell
Pharmaceutical
Eupraxia Pharmaceuticals
Canada
Biography
Eupraxia founder James Helliwell holds a medical degree from the University of British Columbia (UBC), with a specialization in anesthesiology. He also received sub-specialty training in cardiac anesthesiology and transplantation, and board certification in Perioperative Echocardiography. Prior to founding Eupraxia, he held a clinical practice at a quaternary academic cardiac center in St. Paul’s Hospital, Vancouver. He also served as Clinical Assistant Professor at the University of British Columbia in the Department of Anesthesiology, Pharmacology and Therapeutics. With an active interest in administration, systems analysis and public policy reform, James has held many positions of leadership, most recently the presidency of the provincial body guiding anesthesiology care in British Columbia. Involvement with Eupraxia is a natural extension, allowing use of his scientific and administrative knowledge to lead a progressive company dedicated to providing patients with innovative pharmacologic treatments to relieve suffering and improve lives.
Research Interest
Pharmacy